z-logo
Premium
Bioresorbable drug‐eluting scaffold restenosis
Author(s) -
Belardi Jorge A.,
Albertal Mariano
Publication year - 2015
Publication title -
catheterization and cardiovascular interventions
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.988
H-Index - 116
eISSN - 1522-726X
pISSN - 1522-1946
DOI - 10.1002/ccd.25974
Subject(s) - medicine , bioresorbable scaffold , scaffold , restenosis , coronary restenosis , intravascular ultrasound , cardiology , drug , percutaneous coronary intervention , biomedical engineering , stent , pharmacology , myocardial infarction
Key Points Bioresorbable coronary scaffold emerges as an attractive alternative to permanent scaffolds. Bioresorbable scaffold restenosis, similar to permanent, appears strongly related to underexpansion. The use of intravascular imaging should be recommended in patients undergoing bioresorbable scaffold implantation

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here